Person:
Von Keudell, Arvind

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Von Keudell

First Name

Arvind

Name

Von Keudell, Arvind
Author's Publications: search.filters.isAuthorOfPublication.74cb95ca-e131-44c2-8600-94619bc7f275

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Publication
    Recurrent Septic Arthritis Due to Achromobacter xylosoxidans in a Patient With Granulomatosis With Polyangiitis
    (Oxford University Press, 2015) Patel, Payal K.; Von Keudell, Arvind; Moroder, Philipp; Appleton, Paul; Wigmore, Robin; Rodriguez, Edward
    We report a case of recurrent Achromobacter xylosoxidans infections including bacteremia, sepsis, septic joints and endocarditis in a 72 year old female with granulomatosis with polyangiitis. Achromobacter xylosoxidans is a gram negative bacteria increasingly identified in immunocompromised patients. Surgical and medical therapy may need to be combined.
  • Thumbnail Image
    Publication
    Mortality Risk Assessment of Total Knee Arthroplasty and Related Surgery After Percutaneous Coronary Intervention
    (Bentham Open, 2016) Von Keudell, Arvind; Thornhill, Thomas; Katz, Jeffrey; Losina, Elena
    Background: The optimal antiplatelet therapy (APT) treatment strategy after Coronary Artery Stenting (CAS) in non-cardiac surgery, such as total knee arthroplasty (TKA) or urgent TKA-related surgery remains unknown. Methods: We built a decision tree model to examine the mortality outcomes of two alternative strategies for APT after CAS use in the perioperative period namely, continuous use and discontinuation. Results: If surgery was performed in the first month after CAS placement, discontinuing APT led to an estimated 30-day post TKA mortality of 10.5%, compared to 1.0% in a strategy with continuous APT use. Mortality with both strategies decreased with longer intervals. Conclusion: Our model demonstrated that APT discontinuation in patients undergoing TKA or urgent TKA related surgery after CAS placement might lead to greater 30-day mortality up to one year.